Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Resident urges board to reconsider vaccine aluminum safety; district clarifies it does not endorse claims
Loading...
Summary
At a school board meeting, a resident read an article challenging FDA-endorsed aluminum-adjuvant safety studies; a district staff member told the audience the district does not vouch for the accuracy of those remarks.
A resident raised concerns about aluminum in vaccine adjuvants during the public-comment period of a school board meeting, and a district staff member later told the audience the district does not endorse or validate those statements.
The comment: "FDA's aluminum adjuvant safety limits are based on deeply flawed science," was read aloud by Susan Taylor Varoni, who told the board she was summarizing an article by JB Handley and cited Midkus (Mitkus) 2011 and follow-up critiques. Varoni urged board members to "listen to your conscience and your intuition" when considering medical exemptions and vaccination policy.
Why it matters: The comment linked scientific critiques of a 2011 pharmacokinetics review to broader concerns about vaccine safety, a subject that can generate public confusion and concern when raised at school board meetings. School boards sometimes oversee student vaccine-policy enforcement and exemption procedures, so public statements in that forum draw attention from parents and staff.
Meeting remarks and board response: After the public comment, a district staff member told the meeting: "I am not in any way a medical professional, medical doctor, or research specialist in the medical field in medicine. However, I feel it's important for me to say... the information related to vaccines that was mentioned here tonight ... does not represent the sentiments of the district, nor does the district claim to know the validity of any of the remarks that were made." The staff member said the district would not present the comments as district positions to livestream viewers.
Discussion versus decision: The remarks were made during the public-comment portion of the meeting and did not trigger any formal action or vote. The board did not take any policy votes or issue a scientific finding at the meeting.
Context and sources: The speaker who addressed the board during public comment referenced the 2011 Mitkus study and subsequent critiques and mentioned work by researchers including Christopher Shaw at the University of British Columbia. Those scientific citations were presented by the public commenter and are not statements of board policy.
What to watch: The board did not propose changes to vaccination policy at this meeting. Any future policy consideration would require formal agenda placement and a board vote.
